As biologics and cell and gene therapies continue to advance, manufacturing infrastructure is emerging as a critical det...
As cell and gene therapies move from clinical promise to commercial reality, the industry is increasingly recognising th...
At BIO International Convention 2026 in San Diego, BioSpectrum Asia spoke with Dr. Christoffer Norn, Co-founder and CEO ...
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced ...
Sonire Therapeutics has received approximately $13 million in non-dilutive funding through Japan’s NEDO Deep-Tech ...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
MindWalk Holdings Corp. is positioning biological data infrastructure as a key bottleneck in AI-enabled drug discovery, ...
Minghui Pharmaceutical has presented complete Phase I/II clinical data for MHB018A, a subcutaneous anti-IGF-1R antibody ...
Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...
Rznomics has presented interim Phase 1/2a clinical data for RZ-001, its RNA editing-based anticancer gene therapy for re...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...
Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...
Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...
As biologics manufacturing continues to evolve, Asia Pacific is emerging as a key region for innovation in process inten...
Temasek Life Sciences Laboratory has highlighted the importance of life sciences research in strengthening Asia’s ...
Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
Renaissance BioScience Corp., a global leader in bioengineered yeast, today announced the filing of a provisional ...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Nutraceutical ingredients innovator SUANNUTRA USA has inked a distribution agreement with Spanish biotech company Fitopl...
